Clinical Presentation, Aetiology, and Outcomes of Meningitis in a Setting of High HIV and TB Prevalence
Table 1
Demographic and baseline characteristics of the study participants.
Variable
(%)
Female gender,
32 (57)
Age group, years,
18–24
8 (14)
25–34
20 (36)
35–49
22 (39)
>49
6 (11)
HIV status,
Positive
44 (79)
Negative
7 (13)
Unknown
5 (9)
% on antiretroviral therapy,
26 (59)
Clinical presentation,
Altered mental status
42 (75)
Neck stiffness
38 (68)
Headache
30 (54)
Fever
24 (43)
Seizures
4 (7)
Baseline biochemistry, median (IQR)
CD4 count, cells/mm3,
100 (53–155)
Na+, mmol/L,
131.0 (128.0–137.3)
K+, mmol/L,
4.0 (3.4–4.9)
eGFR, mL/min,
57 (26–78)
ALT, U/L,
39 (27–77)
Hb, g/dL,
11.0 (9.0–13.0)
PLT, ×103/L,
273 (186–336)
Data presented as (%) unless otherwise stated; ALT: alanine transaminase; Hb: haemoglobin; : number of patients; : total number of patients for whom the analysis was performed; PLT: platelets.
